Streetbeat News

Stock Prices

AMPS

Altus Power shares are trading higher following the announcement of better-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:52 pm

ARRY

Array Technologies' shares surged following the announcement of their Q1 sales results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:51 pm

MNTK

Montauk Renewables (NASDAQ:MNTK) reported Q1 2024 earnings of $0.01 per share, meeting consensus estimates but missing sales forecasts with $38.787M versus the expected $44.921M. This represents a significant improvement from the previous year, with earnings up 133.33% and sales increasing by 102.50%.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:51 pm

ANDE

Pat Bowe, the current President and CEO of The Andersons, Inc. (NASDAQ:ANDE), has been elected as the new chairman of the board, succeeding Michael J. Anderson who is retiring. Anderson has been with the company since 1999, serving as chairman since 2009. Bowe, who joined The Andersons in 2015, is recognized for his over 40 years of leadership and strategic insight, promising continued growth and success for the company.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:51 pm

FIGS

FIGS shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:51 pm

DNA

Ginko Bioworks Holdings reported worse-than-expected Q1 sales results, leading to a decrease in their share price.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:50 pm

FIHL

Fidelis Insurance Holdings (FIHL) reported Q1 2024 adjusted EPS of $0.74, surpassing the $0.62 estimate, but its sales of $520M fell short of the expected $912.727M. While EPS decreased by 12.94% from last year, sales saw a 26% increase.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:50 pm

NVTS

Navitas Semiconductor's stock trades lower following the announcement of Q1 adjusted EPS results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:50 pm

DNA

Ginkgo Bioworks Holdings, Inc. (NASDAQ:DNA) reported Q1 sales of $38 million, missing analyst estimates by 17.47% and marking a 52.91% decrease year-over-year, primarily due to a ramp down in K-12 testing in its Biosecurity segment. Cell Engineering revenue decreased by 18%, while Biosecurity revenue was $10 million with an 8% gross profit margin. CEO Jason Kelly expressed disappointment and announced a plan for adjusted EBITDA break-even by end of 2026, including significant cost reductions.

Portfolio Pulse from Erica Kollmann

May 09, 2024 | 8:50 pm

EVBG

Everbridge reported Q1 2024 adjusted EPS of $0.18, missing the $0.39 estimate, and sales of $111.4M, below the $112.098M estimate. This represents a 2.89% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:49 pm